Fludarabine plus cyclophosphamide induces better response rates and progression-free survival across all age and risk groups in the LRF CLL4 trial (on behalf of the UKNCRI CLL Trials Group)
| Main Authors: | , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
2006
|
| _version_ | 1797068754643845120 |
|---|---|
| author | Catovsky, D Richards, S Dearden, C Matutes, E Dyer, M Hillmen, P |
| author_facet | Catovsky, D Richards, S Dearden, C Matutes, E Dyer, M Hillmen, P |
| author_sort | Catovsky, D |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T22:14:39Z |
| format | Conference item |
| id | oxford-uuid:52fba4f6-3e74-4b98-9652-8274df39a5e4 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T22:14:39Z |
| publishDate | 2006 |
| record_format | dspace |
| spelling | oxford-uuid:52fba4f6-3e74-4b98-9652-8274df39a5e42022-03-26T16:28:50ZFludarabine plus cyclophosphamide induces better response rates and progression-free survival across all age and risk groups in the LRF CLL4 trial (on behalf of the UKNCRI CLL Trials Group)Conference itemhttp://purl.org/coar/resource_type/c_5794uuid:52fba4f6-3e74-4b98-9652-8274df39a5e4Symplectic Elements at Oxford2006Catovsky, DRichards, SDearden, CMatutes, EDyer, MHillmen, P |
| spellingShingle | Catovsky, D Richards, S Dearden, C Matutes, E Dyer, M Hillmen, P Fludarabine plus cyclophosphamide induces better response rates and progression-free survival across all age and risk groups in the LRF CLL4 trial (on behalf of the UKNCRI CLL Trials Group) |
| title | Fludarabine plus cyclophosphamide induces better response rates and progression-free survival across all age and risk groups in the LRF CLL4 trial (on behalf of the UKNCRI CLL Trials Group) |
| title_full | Fludarabine plus cyclophosphamide induces better response rates and progression-free survival across all age and risk groups in the LRF CLL4 trial (on behalf of the UKNCRI CLL Trials Group) |
| title_fullStr | Fludarabine plus cyclophosphamide induces better response rates and progression-free survival across all age and risk groups in the LRF CLL4 trial (on behalf of the UKNCRI CLL Trials Group) |
| title_full_unstemmed | Fludarabine plus cyclophosphamide induces better response rates and progression-free survival across all age and risk groups in the LRF CLL4 trial (on behalf of the UKNCRI CLL Trials Group) |
| title_short | Fludarabine plus cyclophosphamide induces better response rates and progression-free survival across all age and risk groups in the LRF CLL4 trial (on behalf of the UKNCRI CLL Trials Group) |
| title_sort | fludarabine plus cyclophosphamide induces better response rates and progression free survival across all age and risk groups in the lrf cll4 trial on behalf of the ukncri cll trials group |
| work_keys_str_mv | AT catovskyd fludarabinepluscyclophosphamideinducesbetterresponseratesandprogressionfreesurvivalacrossallageandriskgroupsinthelrfcll4trialonbehalfoftheukncriclltrialsgroup AT richardss fludarabinepluscyclophosphamideinducesbetterresponseratesandprogressionfreesurvivalacrossallageandriskgroupsinthelrfcll4trialonbehalfoftheukncriclltrialsgroup AT deardenc fludarabinepluscyclophosphamideinducesbetterresponseratesandprogressionfreesurvivalacrossallageandriskgroupsinthelrfcll4trialonbehalfoftheukncriclltrialsgroup AT matutese fludarabinepluscyclophosphamideinducesbetterresponseratesandprogressionfreesurvivalacrossallageandriskgroupsinthelrfcll4trialonbehalfoftheukncriclltrialsgroup AT dyerm fludarabinepluscyclophosphamideinducesbetterresponseratesandprogressionfreesurvivalacrossallageandriskgroupsinthelrfcll4trialonbehalfoftheukncriclltrialsgroup AT hillmenp fludarabinepluscyclophosphamideinducesbetterresponseratesandprogressionfreesurvivalacrossallageandriskgroupsinthelrfcll4trialonbehalfoftheukncriclltrialsgroup |